In The News
Walkasins® clinical research published April 30, 2019 in PLOS ONE finds short-term use of device lowers fall-risk for peripheral neuropathy patients.
RxFunction Announces Hiring of VP of Sales Frank Oschell.
RxFunction Further Strengthens IP Portfolio with Newly Issued Patent
RxFunction Named 2018 Tekne Award Winner
RxFunction Named Finalist for Minnesota High Tech Association 2018 Tekne Award
EVENT: RxFunction CTO, Co-founder, Lars Oddsson, PhD, Presents at ACRM 2018
RxFunction Announces Hiring of CFO Mary Anderson.
RxFunction Announces Plans for Long-Term Clinical Trial for Walkasins®.
Local Medical Tech Industry Leaders Richard Nigon and Kevin H. Roche Join RxFunction, Inc. Board of Directors
Medical Start-Up RxFunction, Inc. Raises $7.5 Million in Series A Funding.
Next Page »
RxFunction, Inc. has recently registered
and listed Walkasins with the FDA,
but Walkasins is not yet available for sale.
© 2019 RxFunction, Inc.